SCHEMBL2653784

SCHEMBL2653784

COC(=O)CCNC(=O)c1ccc(CCCCCOc2ccc(-c3ccc(C(C)(C)C)cc3)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.53
RAB9A P51151 5/20 0.53
ESRRG P62508 4/20 0.53
POLB P06746 1/20 0.53
CASP3 P42574 1/20 0.53
SENP7 Q9BQF6 1/20 0.53
EPHX2 P34913 4/20 0.49
NR1H4 Q96RI1 4/20 0.49
ESRRB O95718 1/20 0.49
L3MBTL1 Q9Y468 2/20 0.48
MEN1 O00255 5/20 0.48
KMT2A Q03164 5/20 0.48
ALDH1A1 P00352 2/20 0.47
GPR35 Q9HC97 1/20 0.46
MAPT P10636 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
NFKB1 P19838 1/20 0.46
NFKB2 Q00653 1/20 0.46
RELA Q04206 1/20 0.46
CA1 P00915 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2654356 1.00 NPC1 (0.53) NPC1RAB9AESRRGPOLBCASP3
SCHEMBL2655081 0.99 NPC1 (0.54) NPC1RAB9AESRRGPOLBCASP3
SCHEMBL2655436 0.96 NPC1 (0.55) NPC1RAB9AESRRGPOLBCASP3
SCHEMBL2656353 0.93 ESRRG (0.55) NPC1RAB9AESRRGPOLBCASP3
SCHEMBL2653990 0.91 MEN1 (0.56) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL2654466 0.91 MEN1 (0.56) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL2655220 0.91 NPC1 (0.57) NPC1RAB9AESRRGPOLBCASP3
SCHEMBL2655124 0.91 NPC1 (0.57) NPC1RAB9AESRRGPOLBCASP3
SCHEMBL2656581 0.91 NPC1 (0.57) NPC1RAB9AESRRGPOLBCASP3
SCHEMBL2653250 0.90 MEN1 (0.57) NPC1RAB9AMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1758853-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2007-03-07 EP disclosed
WO-2005123668-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2005-12-29 WO disclosed